| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 02/16/2005 | CN1189471C Phosphonocephem compound |
| 02/16/2005 | CN1189470C Phosphorus-comprising materials, their preparation and use |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855849 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation |
| 02/15/2005 | US6855847 Asymmetric hydrogenation |
| 02/15/2005 | US6855841 Process for the preparation of N-phosphonomethylglycine |
| 02/15/2005 | US6855783 Supported metallocene catalysts |
| 02/15/2005 | US6855757 Reacting yellow phosphorus with methyl chloride; esterification with alcohol; hydrolysis |
| 02/15/2005 | US6855702 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 02/15/2005 | US6855695 Water-soluble SHPs as novel alkylating agents |
| 02/15/2005 | US6855657 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions |
| 02/10/2005 | WO2005012417A1 Flameproof thermoplastic resin composition |
| 02/10/2005 | WO2005012324A2 Nucleobase phosphonate analogs for antiviral treatment |
| 02/10/2005 | WO2005012314A1 Process for controlling crystal structure of risedronate |
| 02/10/2005 | WO2005012313A2 Aldolase-inhibiting aromatic compounds |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2004110979A3 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 02/10/2005 | WO2004094442A3 Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols |
| 02/10/2005 | WO2004048526A3 MODULATION OF HIF1α AND HIF2α EXPRESSION |
| 02/10/2005 | US20050033090 Process for the preparation of cinnamaldehyde compounds |
| 02/10/2005 | US20050033073 Alkyl group VA metal compounds |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033051 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection using modified nucleotides; viricides |
| 02/10/2005 | US20050033038 Reaction of phosphorothioate derivative with phenolic compound |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032802 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 02/10/2005 | US20050032752 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/10/2005 | US20050032744 Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds |
| 02/10/2005 | US20050032676 Administering lipidated glycopeptide antibiotic and cyclodextrin, reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release |
| 02/10/2005 | US20050032147 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes |
| 02/10/2005 | US20050031888 injecting orhanometallic compound into hot solvent; forming intermetallics, alloys; photoliminescence efficiency |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | CA2533966A1 Nucleobase phosphonate analogs for antiviral treatment |
| 02/10/2005 | CA2531102A1 Aldolase-inhibiting aromatic compounds |
| 02/09/2005 | EP1505071A1 Use of a supplemental promoter in conjunction with a carbon-supported, noble metal containing catalyst in liquid phase oxidation reactions |
| 02/09/2005 | EP1505057A1 Method of purifying quaternary alkylammonium salt and quaternary alkylammonium salt |
| 02/09/2005 | EP1504019A1 Platinum complexes having antitumor activity |
| 02/09/2005 | EP1504014A2 Process for preparation of cyclic prodrugs of pmea and pmpa |
| 02/09/2005 | EP1504013A2 Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators |
| 02/09/2005 | EP1504012A1 Preparation of biphosphonic acids and salts thereof |
| 02/09/2005 | EP1503768A1 Inositol pyrophosphates, and methods of use thereof |
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/09/2005 | EP1175382B1 Method for the dihydroxylation of olefins using transition-metal catalysts |
| 02/09/2005 | EP1094986B1 water purification system and method |
| 02/09/2005 | CN1576280A Alkoxyamine derived from beta-phosphorylated nitroxide and its use in preparation of mono- or polyalkoxyamine |
| 02/09/2005 | CN1188422C Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) Propylcarbamate |
| 02/09/2005 | CN1188421C Process for the preparation of condensed phosphoric esters |
| 02/09/2005 | CN1188391C Method of recovering and cyclically utilizing methanesulfonic acid phosphorus acid |
| 02/09/2005 | CN1188037C Process for making ammonium glyphosate flakes |
| 02/08/2005 | US6852870 Omega-3 fatty acids in the treatment of depression |
| 02/08/2005 | US6852843 Phosphorus supported carbene transition metal complexes |
| 02/08/2005 | US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852661 Catalyst comprising a metal complex of the VIII subgroup based on a phosphine amidite ligand and its utilization for hydroformylation and hydrocyanation |
| 02/08/2005 | US6852548 Produce light energy when decomposed; stable at room temperature |
| 02/03/2005 | WO2005010014A1 Process for producing optically active dimer of phosphorus heterocycle |
| 02/03/2005 | WO2005010013A1 Novel optically active phosphorus-chiral diphosphetanes, intermediates of the same, and transition metal complexes containing the diphosphetanes as the ligand |
| 02/03/2005 | WO2005010011A2 Methods of synthesis of acyloxyalkyl compounds |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009963A1 Chelants and macrocyclic metal complex radiopharmaceuticals tihereof |
| 02/03/2005 | WO2005009934A2 Two-stage hydroformylation |
| 02/03/2005 | WO2005009348A2 Substituted purine derivatives |
| 02/03/2005 | US20050027124 Phosphine-borane complex enantiomorph compounds in solvents and in the presence of nickel catalysts |
| 02/03/2005 | US20050027013 LTA4 hydrolase inhibitors |
| 02/03/2005 | US20050026874 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility |
| 02/03/2005 | US20050026873 Type-I methionyl aminopeptidases inhibitors in antibacterial targeting |
| 02/03/2005 | US20050026872 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor |
| 02/03/2005 | US20050026869 Process for controlling crystal structure of risedronate |
| 02/03/2005 | US20050026868 Phosphorus-containing macrocycles |
| 02/03/2005 | US20050026864 Bisphosphonate conjugates and methods of making and using the same |
| 02/03/2005 | US20050026820 reducing nephrotoxicity; increased therapeutic window for the glycopeptide to allow a greater amount to be administered |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
| 02/02/2005 | EP1501842A2 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501840A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and polymers therefrom |
| 02/02/2005 | EP1501810A1 Ionic liquids |
| 02/02/2005 | EP1430065B1 Beta-ketophosphonates |
| 02/02/2005 | EP1280812B1 Cyclipostins, a method for their production and the use of the same |
| 02/02/2005 | EP1181283B1 Diaminothiazoles and their use for inhibiting protein kinases |
| 02/02/2005 | EP1027399B1 Trypticene derivatives and their use in optoelectronic devices, in particular as electroluminescent materials |
| 02/02/2005 | CN1575066A Light emitting device formed using rare earth complex and luminescent medium |
| 02/02/2005 | CN1572795A Process for producing phosphite |
| 02/02/2005 | CN1187361C Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 02/02/2005 | CN1187360C Phosphonic acid derivatives having carboxypeptidase B inhibitory activity |
| 02/01/2005 | US6849753 Process for preparation of half-vanadocene compound |
| 02/01/2005 | US6849752 Reacting carboxy or carboxamide or thiocarboxy compound with halogen-containing compound in presence of reaction aid containing element from groups 1-4 and 11-14 of periodic table; support electrolyte for lithium batteries, capacitors |
| 02/01/2005 | US6849656 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 02/01/2005 | US6849642 Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 01/27/2005 | WO2005007643A1 Novel acridine derivatives and use thereof as medicaments |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007634A1 3-hydroxy-4-oxo-1,2,3-triazines and derivatives thereof for amide and ester bond formation |
| 01/27/2005 | WO2005007603A2 Fluorocombretastatin and derivatives thereof |
| 01/27/2005 | WO2005007602A1 Minimization of ligand degradation products, of reversion of same to useful phosphine ligands |
| 01/27/2005 | WO2005007084A2 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs |
| 01/27/2005 | WO2004108735A3 Polymer compositions containing stabilizer compounds comprising tricyclodecilmethyl groups |
| 01/27/2005 | WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 01/27/2005 | WO2004096234A3 Kinase inhibitor phosphonate conjugates |
| 01/27/2005 | WO2004085418A3 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |